108 related articles for article (PubMed ID: 2469230)
1. Immunohistologic staining of renal transplant biopsies with monoclonal antibody WT14: a new parameter for the diagnosis of rejection.
Bogman MJ; Dooper PM; Assmann KJ; van de Winkel JG; Tax WJ; Maass CN; Koene RA
Transplant Proc; 1989 Feb; 21(1 Pt 2):1886-7. PubMed ID: 2469230
[No Abstract] [Full Text] [Related]
2. Diagnostic value of monocyte/macrophage (WT14) staining in renal allograft biopsies.
Bogman MJ; Dooper MM; Hoitsma AJ; de Jong MC; Tax WJ; Assmann KJ; Koene RA
Transplant Proc; 1991 Feb; 23(1 Pt 2):1293-4. PubMed ID: 1703337
[No Abstract] [Full Text] [Related]
3. The extent of peritubular CD14 staining in renal allografts as an independent immunohistological marker for acute rejection.
Dooper IM; Hoitsma AJ; Maass CN; Assmann KJ; Tax WJ; Koene RA; Bogman MJ
Transplantation; 1994 Oct; 58(7):820-7. PubMed ID: 7524205
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of renal allograft rejection by macrophage immunostaining with a CD14 monoclonal antibody, WT14.
Bogman MJ; Dooper IM; van de Winkel JG; Tax WJ; Hoitsma AJ; Assmann KJ; Ruiter DJ; Koene RA
Lancet; 1989 Jul; 2(8657):235-8. PubMed ID: 2474119
[TBL] [Abstract][Full Text] [Related]
5. Evaluation by histology, immunohistology and PCR of protocollized renal biopsies 1 week post-transplant in relation to subsequent rejection episodes.
Kooijmans-Coutinho MF; Bruijn JA; Hermans J; Schindler R; Frei U; Schrama E; van Es LA; Daha MR; van der Woude FJ
Nephrol Dial Transplant; 1995; 10(6):847-54. PubMed ID: 7566615
[TBL] [Abstract][Full Text] [Related]
6. Detection of interstitial increase in macrophages, characteristic of acute interstitial rejection, in routinely processed renal allograft biopsies using the monoclonal antibody KP1.
Dooper IM; Bogman MJ; Hoitsma AJ; Maass CN; Assmann KJ; Koene RA
Transpl Int; 1992 Sep; 5(4):209-13. PubMed ID: 1384532
[TBL] [Abstract][Full Text] [Related]
7. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules.
Andersen CB; Ladefoged SD; Larsen S
APMIS; 1994 Jan; 102(1):23-37. PubMed ID: 7513171
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of cyclosporine A-induced nephrotoxicity from acute rejection in renal transplantation using fine-needle aspiration biopsies.
Zannier A; Mutin M; Touraine JL; Traeger J
Transplant Proc; 1987 Oct; 19(5):3630-2. PubMed ID: 3313874
[No Abstract] [Full Text] [Related]
9. Immunohistological analysis of renal allograft biopsies from cyclosporin-treated patients. Induced HLA-class II antigen expression does not exclude a diagnosis of cyclosporin nephrotoxicity.
Fuggle SV; McWhinnie DL; Morris PJ
Transpl Int; 1989 Oct; 2(3):123-8. PubMed ID: 2679626
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine monitoring with polyclonal and specific monoclonal antibodies during episodes of renal allograft dysfunction.
Holt DW; Marsden JT; Johnston A; Taube DH
Transplant Proc; 1989 Feb; 21(1 Pt 2):1482-4. PubMed ID: 2652475
[No Abstract] [Full Text] [Related]
11. Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection, or good renal function: comparative high-performance liquid chromatography and monoclonal radioimmunoassay studies.
Rosano TG; Pell MA; Freed BM; Dybas MT; Lempert N
Transplant Proc; 1988 Apr; 20(2 Suppl 2):330-8. PubMed ID: 3284076
[No Abstract] [Full Text] [Related]
12. Monoclonal antibody staining of cells cultured from human renal transplant biopsies.
Horsburgh T; Brown SL; Veitch PS
Transplant Proc; 1989 Feb; 21(1 Pt 1):358. PubMed ID: 2468219
[No Abstract] [Full Text] [Related]
13. Analysis of infiltrating lymphocytes from fine needle aspiration biopsies in kidney transplant patients by a rapid and sensitive immunomagnetic method.
Pfeffer PF; Gjertsen HA; Gaudernack G; Lexow PB; Sodal G; Thorsby E
Transplant Proc; 1989 Feb; 21(1 Pt 1):354-5. PubMed ID: 2495609
[No Abstract] [Full Text] [Related]
14. Analysis of renal transplant using fine needle aspiration biopsies with monoclonal antibodies.
Mizuiri S; Ohara T; Aikawa A; Mitsuo K; Hasegawa A
Transplant Proc; 1989 Jun; 21(3):3452-4. PubMed ID: 2662488
[No Abstract] [Full Text] [Related]
15. Fine-needle aspiration biopsy: a reproducibility study and a correlation with the tru-cut biopsy in the evaluation of renal allotransplants.
Sobh MA; Moustafa FE; Ghoneim MA
Nephrol Dial Transplant; 1987; 2(6):562-7. PubMed ID: 3126458
[TBL] [Abstract][Full Text] [Related]
16. Immunohistology or conventional histology for the diagnosis of renal allograft rejection?
McWhinnie DL; Hughes D; Fuggle SV; Dunnill MS; Carter NP; Morris PJ
Transplant Proc; 1989 Feb; 21(1 Pt 2):1888-9. PubMed ID: 2652613
[No Abstract] [Full Text] [Related]
17. Comparison of the utility of 3H-based specific monoclonal antibody assay on whole blood samples with the fluorescence polarization nonspecific immunoassay on serum samples for diagnosis of adverse events in renal transplant patients.
Kahan BD; Napoli K; Welsh M; Grevel J; Rutzky LP
Transplant Proc; 1990 Jun; 22(3):1274-9. PubMed ID: 2190389
[No Abstract] [Full Text] [Related]
18. An approach to the renal transplant recipient with persistent one-month graft nonfunction.
Gritsch HA; Koyle MA; Ward HJ; Sender MB; Rajfer J; Cohen AH; Glassock RJ; Mickey MR
Transplant Proc; 1989 Feb; 21(1 Pt 2):1527-8. PubMed ID: 2652492
[No Abstract] [Full Text] [Related]
19. Reflections on use of the renal biopsy as the "gold standard" in distinguishing transplant rejection from cyclosporine nephrotoxicity.
Solez K; McGraw DJ; Beschorner WE; Kone BC; Racusen LC; Whelton A; Burdick JF
Transplant Proc; 1985 Aug; 17(4 Suppl 1):123-33. PubMed ID: 3927535
[No Abstract] [Full Text] [Related]
20. HLA-class II antigen induction does not exclude a diagnosis of cyclosporine nephrotoxicity.
Fuggle SV; McWhinnie DL; Morris PJ
Transplant Proc; 1989 Feb; 21(1 Pt 2):1525-6. PubMed ID: 2652491
[No Abstract] [Full Text] [Related]
[Next] [New Search]